Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 1
1973 1
1975 1
1976 1
1978 1
1979 2
1982 2
1984 1
1985 1
1988 1
1989 1
1990 3
1991 2
1996 1
1999 1
2001 1
2004 2
2005 2
2006 1
2007 3
2008 3
2009 3
2010 4
2011 3
2012 2
2013 3
2014 5
2015 4
2016 5
2017 11
2018 8
2019 8
2020 8
2021 24
2022 11
2023 16
2024 25
2025 37
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. N Engl J Med. 2025. PMID: 40532178 Clinical Trial.
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.
Galsky MD, Witjes JA, Gschwend JE, Milowsky MI, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Agerbaek M, Jha G, Stenner F, Ye D, Giudici F, Dutta S, Askelson M, Nasroulah F, Zhang J, Brophy L, Bajorin DF. Galsky MD, et al. Among authors: jha g. J Clin Oncol. 2025 Jan;43(1):15-21. doi: 10.1200/JCO.24.00340. Epub 2024 Oct 11. J Clin Oncol. 2025. PMID: 39393026 Free PMC article. Clinical Trial.
Mapping genetic diversity with the GenomeIndia project.
Bhattacharyya C, Subramanian K, Uppili B, Biswas NK, Ramdas S, Tallapaka KB, Arvind P, Rupanagudi KV, Maitra A, Nagabandi T, De T, Singh K, Sharma P, Sharma N, Raghav SK, Prasad P, Soniya EV, Jaleel A, Nelson Sathi S, Joshi M, Joshi C, Lahiri M, Dixit S, Shashidhara LS, Senthil Kumar N, Lalhruaitluanga H, Nundanga L, Shivakumar V, Venkatasubramanian G, Rao NP, Ganie MA, Wani IA, Jha G, Dalal A, Bashyam MD, Varadwaj PK, Bs S, Simmhan Y, Jain C, Sundar D, Gupta I, Yadav P, Sinha H, Narayanan M, Raman K, Padinjat R, Sabarinathan R; GenomeIndia Consortium; Narahari Y, Ravindranath V, Thangaraj K, Sowpati DT, Faruq M, Basu A, Kahali B. Bhattacharyya C, et al. Among authors: jha g. Nat Genet. 2025 Apr;57(4):767-773. doi: 10.1038/s41588-025-02153-x. Nat Genet. 2025. PMID: 40200122 No abstract available.
Tumor heterogeneity in retinoblastoma: a literature review.
Pallavi R, Soni BL, Jha GK, Sanyal S, Fatima A, Kaliki S. Pallavi R, et al. Among authors: jha gk. Cancer Metastasis Rev. 2025 Apr 22;44(2):46. doi: 10.1007/s10555-025-10263-5. Cancer Metastasis Rev. 2025. PMID: 40259075 Free PMC article. Review.
Bacterial Reverse Mutation Test: Ames Test.
Sharma D, Mishra S, Jha G, Tomar B, Rath SK. Sharma D, et al. Among authors: jha g. Methods Mol Biol. 2026;2986:3-15. doi: 10.1007/978-1-0716-4976-3_1. Methods Mol Biol. 2026. PMID: 41273676
198 results